ASND News
Ascendis Pharma A/S
$256.82
+$3.37(+1.33%)
59
Overall
20
Value
91
Tech
68
Quality
Market Cap
$16.92B
Volume
883.85K
52W Range
$188.07 - $282.15
Target Price
$307.82
ASND news: the latest Ascendis Pharma A/S headlines, press releases and market updates, newest first.
Latest ASND News
- Ascendis Pharma Receives Positive EU Orphan-Drug Opinion for TransCon CNPTipRanks Auto-Generated Newsdesk · Nov 6, 2026
- Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Fractyl Health, Inc. (GUTS) and Ascendis Pharma (ASND)TipRanks Newsroom · Oct 19, 2026
- Ascendis Pharma Wins EMA Panel Backing for TransCon CNP in Pediatric AchondroplasiaTipRanks Auto-Generated Newsdesk · Oct 16, 2026
- Ascendis Pharma (ASND) Receives a New Rating from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Ascendis Pharma Grants New Employee Warrants and Updates Articles of AssociationTipRanks Auto-Generated Newsdesk · Oct 14, 2026
- RBC Capital Sticks to Its Buy Rating for Ascendis Pharma (ASND)TipRanks Auto-Generated Intelligence Newsdesk · Oct 9, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ASND | $256.82 | +1.3% | 883.85K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |